B. Riley analyst Bryan Maher lowered the firm’s price target on Alerislife to $1.50 from $2 and keeps a Neutral rating on the shares following the "mixed" Q3 results.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ALR: